BiotechTube
Home/SONIRE Therapeutics/Tohru Satoh
TS

Tohru Satoh

CEO

SONIRE Therapeutics

Therapeutic Areas

Oncology

SONIRE Therapeutics Pipeline

DrugIndicationPhase
Next-Gen US-guided HIFU Therapy SystemPancreatic CancerPreclinical